NobelZygoma™
Treat your most challenging cases. Transform more patients’ lives.
Building on over 25 years of clinical experience, Nobel Biocare zygomatic implants show remarkable long-term survival rates, with an average implant survival of 96.1% after 10+ years.1
NobelZygoma™ - The implant for severe resorption in maxillary bone.
Discover NobelZygoma, the implant that anchors in the zygomatic bone. It is an implant system for an immediate protocol with graftless treatment that also offers prosthetic versatility. This shortens time-to-teeth for increased patient satisfaction.1
Graftless treatment solution
NobelZygoma, the implant system for immediate loading with a graftless protocol and a wide choice of temporary prosthetic options.
Designed to significantly shorten time-to-teeth for increased patient satisfaction.
More than 25 years of clinical experience
81 clinical studies published
2700+ patients treated
6500+ implants placed
97.0% survival rate*
*mean survival rate across publications and maximum follow-up of over 20 years.
Backed with science
Proven and immediate
The graftless solution that allows immediate loading, backed by 74 studies.
Long-term success
Excellent long-term survival rates at implant and prosthetic level, with over 25 years' follow up.2
Advanced treatment option
Immediate improvement in quality of life for patients with severe maxillary bone resorption.
-
Immediate rehabilitation of a severely resorbed maxilla using zygomatic implantsDr. Rubén Davó, Spain
-
Successful 10-year outcomes of NobelProcera® restoration in hybrid All-on-4® treatment conceptDr. Armando Lopes and Carlos Moura Guedes, Portugal
-
Long-term result of Quad Zygoma Protocolby Davo et al. 2023
-
Retrospective clinical study with 217 zygomatic implantsby Bonnet et al. 2022
-
"The patient was told bone harvest and grafting was the only option."Dr. Alexandra Marques and Dr. Rubén Davó
References
*Loading with a provisional fixed restoration on the day of surgery is possible, provided patient criteria are met and adequate implant stability is achieved.
- Nobel Biocare. Data on file.
- Vrielinck L, Moreno-Rabie C, Coucke W, Jacobs R, Politis C. Retrospective cohort assessment of survival and complications of zygomatic implants in atrophic maxillae. Clin Oral Implants Res. 2023;34(2):148-56.